Virtual reality iliac angioplasty simulator introduction planned for December RSNA meeting.
This article was originally published in The Gray Sheet
Executive Summary
VIRTUAL REALITY ILIAC ANGIOPLASTY SIMULATOR NEARING COMPLETION, according to Massachusetts General Hospital developers Steve Dawson, MD, and John Kaufman, PhD. The simulator, intended for use in medical training, provides visual and tactile feedback to catheter and guidewire manipulations. The researchers plan to unveil the device at the Dec. 1-6 meeting of the Radiological Society of North America in Chicago, but may have it ready for the 3rd International Symposium on Cardiovascular and Interventional Radiology to be held Oct. 8-11 in Boston.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.